<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03097484</url>
  </required_header>
  <id_info>
    <org_study_id>15-0159-F2L</org_study_id>
    <nct_id>NCT03097484</nct_id>
  </id_info>
  <brief_title>The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels</brief_title>
  <official_title>The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John M. Daniel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the effectiveness of lavender and chamomile aromatherapy of mitigation of symptoms
      of Neonatal Abstinence Syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The United States, Appalachia, Eastern Kentucky in particular, is in the midst of a major
      opioid abuse epidemic. This current epidemic is driven by misuse of prescription painkillers,
      i.e. Subutex and Saboxone. As prescription pills become more expensive and harder to acquire,
      addicts are seeking similar, cheaper drugs; such as heroin. From 1998 to 2011, the prevalence
      of opioid abuse and dependence amongst pregnant women has increased by 127%, from 1.7 per
      1000 to 3.9 per 1000. Neonatal Abstinence Syndrome (NAS) or neonatal opioid withdrawal
      syndrome is a condition produces gastrointestinal and autonomic neurologic dysfunction.
      Infants with severe withdrawal experience dysregulation of autonomic functions, resulting in
      feeding difficulty, diarrhea, excessive sleepiness, and tremors.Nearly two thirds of all
      babies exposed to opioids during gestation will require admission to a neonatal intensive
      care unit for management of withdrawal symptoms. During a typical year the Neonatal Intensive
      Care Unit (NICU) at Kentucky Children's Hospital admits approximately 100-120 infants
      exhibiting NAS symptoms; these infants have a typical length of stay of 24 days if they
      require pharmacologic treatment.

      The mainstay of treatment for NAS involves opioid replacement therapy with morphine to
      minimize withdrawal symptoms. Once symptoms are well controlled, the infant is said to have
      been &quot;captured.&quot; At this point a slow weaning of his morphine dose occurs. The infants'
      clinical status is assessed with the Finnegan Scoring system, which examines symptoms such as
      crying, excessive sleepiness or difficulty sleeping, insomnia, or tremors along with
      objective findings such as temperature and respiratory rate.

      In addition to pharmacotherapy, alternative and complementary medicine techniques are slowly
      entering the NAS treatment algorithm. Treatments such as music therapy infant massage,
      kangaroo care, aromatherapy, and acupressure are now employed in NICUs in addition to
      traditional opioids replacement. However, few studies exist in the literature to evaluate
      their effectiveness.

      Aromatherapy is the practice of using natural essential oils to achieve a desired effect in
      an individual. Scents such as lavender and chamomile have been documented to have a soothing
      calming effect. Studies involving infants shown that lavender not only reduce crying and
      enhance sleep, but also reduce levels of salivary cortisol, a stress hormone. Additionally,
      aromatherapy is currently used as an adjunctive therapy at the University of Kentucky's
      Markey Cancer Center.

      Salivary cortisol is a non-invasive biomarker that has proven useful for monitoring stress in
      neonates. It is a simple and painless method for monitoring the stress hormone cortisol.
      Salivary cortisol has been used successfully in infants as a method to assess infant stress
      associated with prone position versus supine positioning.These studies have shown that
      salivary cortisol levels vary with stressful or soothing stimuli.

      To date, no dangerous or deleterious effects have been described from traditional
      inhalational use of aromatherapy or with salivary cortisol sampling. Studies have shown
      aromatherapy to be an effective adjunctive therapy by proving a calming effect. In our
      patient population it may prove to be a useful complimentary therapy ultimately reducing
      infant stress, hospital length of stay, and burden of opioid use. Additionally, salivary
      cortisol's ease of collection and non-invasive nature make it an ideal biomarker to study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 25, 2015</start_date>
  <completion_date type="Actual">April 30, 2017</completion_date>
  <primary_completion_date type="Actual">April 30, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Hospitalization</measure>
    <time_frame>Up to 4 months</time_frame>
    <description>How long the infant remains hospitalized.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Medication Therapy</measure>
    <time_frame>Up to 4 months</time_frame>
    <description>How long the infant requires medication to treat symptoms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Neonatal Abstinence Syndrome</condition>
  <condition>Aromatherapy</condition>
  <arm_group>
    <arm_group_label>Standard therapy plus Aromatherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard therapy ALONE</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lavender and chamomile essential oils</intervention_name>
    <description>Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.</description>
    <arm_group_label>Standard therapy plus Aromatherapy</arm_group_label>
    <other_name>Lavendula, chamomilla</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants greater than or equal to 36 weeks EGA

          -  Intrauterine opioid exposure

          -  Primary diagnosis of NAS

          -  Parental permission to participate

        Exclusion Criteria:

          -  Infants less than 36 weeks EGA

          -  Major congenital anomalies

          -  Latrogenic drug withdrawal

          -  Diagnosis of infection or respiratory distress

          -  Prior initiation of opioid replacement therapy

          -  Non-English speaking

          -  Infants with respiratory conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John M Daniel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Ang JY, Lua JL, Mathur A, Thomas R, Asmar BI, Savasan S, Buck S, Long M, Shankaran S. A randomized placebo-controlled trial of massage therapy on the immune system of preterm infants. Pediatrics. 2012 Dec;130(6):e1549-58. doi: 10.1542/peds.2012-0196. Epub 2012 Nov 12.</citation>
    <PMID>23147978</PMID>
  </results_reference>
  <results_reference>
    <citation>Cândia MF, Osaku EF, Leite MA, Toccolini B, Costa NL, Teixeira SN, Costa CR, Piana PA, Cristovam MA, Osaku NO. Influence of prone positioning on premature newborn infant stress assessed by means of salivary cortisol measurement: pilot study. Rev Bras Ter Intensiva. 2014 Apr-Jun;26(2):169-75. English, Portuguese.</citation>
    <PMID>25028952</PMID>
  </results_reference>
  <results_reference>
    <citation>Conde-Agudelo A, Díaz-Rossello JL. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev. 2014 Apr 22;(4):CD002771. doi: 10.1002/14651858.CD002771.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD002771.</citation>
    <PMID>24752403</PMID>
  </results_reference>
  <results_reference>
    <citation>Field T, Diego M, Hernandez-Reif M, Cisneros W, Feijo L, Vera Y, Gil K, Grina D, Claire He Q. Lavender fragrance cleansing gel effects on relaxation. Int J Neurosci. 2005 Feb;115(2):207-22.</citation>
    <PMID>15764002</PMID>
  </results_reference>
  <results_reference>
    <citation>Field T, Field T, Cullen C, Largie S, Diego M, Schanberg S, Kuhn C. Lavender bath oil reduces stress and crying and enhances sleep in very young infants. Early Hum Dev. 2008 Jun;84(6):399-401. Epub 2007 Nov 28.</citation>
    <PMID>18053656</PMID>
  </results_reference>
  <results_reference>
    <citation>Filippelli AC, White LF, Spellman LW, Broderick M, Highfield ES, Sommers E, Gardiner P. Non-Insertive Acupuncture and Neonatal Abstinence Syndrome: A Case Series from an Inner City Safety Net Hospital. Glob Adv Health Med. 2012 Sep;1(4):48-52.</citation>
    <PMID>24078899</PMID>
  </results_reference>
  <results_reference>
    <citation>Hayes MJ, Brown MS. Epidemic of prescription opiate abuse and neonatal abstinence. JAMA. 2012 May 9;307(18):1974-5. doi: 10.1001/jama.2012.4526. Epub 2012 Apr 30.</citation>
    <PMID>22546607</PMID>
  </results_reference>
  <results_reference>
    <citation>Loewy J, Stewart K, Dassler AM, Telsey A, Homel P. The effects of music therapy on vital signs, feeding, and sleep in premature infants. Pediatrics. 2013 May;131(5):902-18. doi: 10.1542/peds.2012-1367. Epub 2013 Apr 15.</citation>
    <PMID>23589814</PMID>
  </results_reference>
  <results_reference>
    <citation>Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014 Dec;121(6):1158-65. doi: 10.1097/ALN.0000000000000472.</citation>
    <PMID>25405293</PMID>
  </results_reference>
  <results_reference>
    <citation>Namazi M, Amir Ali Akbari S, Mojab F, Talebi A, Alavi Majd H, Jannesari S. Aromatherapy with citrus aurantium oil and anxiety during the first stage of labor. Iran Red Crescent Med J. 2014 Jun;16(6):e18371. doi: 10.5812/ircmj.18371. Epub 2014 Jun 5.</citation>
    <PMID>25068058</PMID>
  </results_reference>
  <results_reference>
    <citation>Olson SL. Bedside musical care: applications in pregnancy, childbirth, and neonatal care. J Obstet Gynecol Neonatal Nurs. 1998 Sep-Oct;27(5):569-75. Review.</citation>
    <PMID>9773369</PMID>
  </results_reference>
  <results_reference>
    <citation>Parlier AB, Fagan B, Ramage M, Galvin S. Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions. South Med J. 2014 Nov;107(11):676-83. doi: 10.14423/SMJ.0000000000000189.</citation>
    <PMID>25365432</PMID>
  </results_reference>
  <results_reference>
    <citation>Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012 May 9;307(18):1934-40. doi: 10.1001/jama.2012.3951. Epub 2012 Apr 30.</citation>
    <PMID>22546608</PMID>
  </results_reference>
  <results_reference>
    <citation>Tang SK, Tse MY. Aromatherapy: does it help to relieve pain, depression, anxiety, and stress in community-dwelling older persons? Biomed Res Int. 2014;2014:430195. doi: 10.1155/2014/430195. Epub 2014 Jul 13.</citation>
    <PMID>25114901</PMID>
  </results_reference>
  <results_reference>
    <citation>Thomas DV. Aromatherapy: mythical, magical, or medicinal? Holist Nurs Pract. 2002 Oct;16(5):8-16. Review.</citation>
    <PMID>12465213</PMID>
  </results_reference>
  <results_reference>
    <citation>Tryphonopoulos PD, Letourneau N, Azar R. Approaches to salivary cortisol collection and analysis in infants. Biol Res Nurs. 2014 Oct;16(4):398-408. doi: 10.1177/1099800413507128. Epub 2013 Oct 16. Review.</citation>
    <PMID>24136995</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2017</study_first_posted>
  <results_first_submitted>April 1, 2019</results_first_submitted>
  <results_first_submitted_qc>April 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 14, 2019</results_first_posted>
  <last_update_submitted>April 23, 2019</last_update_submitted>
  <last_update_submitted_qc>April 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>John M. Daniel</investigator_full_name>
    <investigator_title>Fellow, Department of Pediatrics, Division of Neonatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neonatal Abstinence Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 27, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT03097484/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Therapy ALONE</title>
          <description>These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
        </group>
        <group group_id="P2">
          <title>Standard Therapy Plus Aromatherapy</title>
          <description>These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.
lavender and chamomile essential oils: Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Therapy ALONE</title>
          <description>These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
        </group>
        <group group_id="B2">
          <title>Standard Therapy Plus Aromatherapy</title>
          <description>These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.
lavender and chamomile essential oils: Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="38"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.14" spread="9"/>
                    <measurement group_id="B2" value="38.86" spread="5"/>
                    <measurement group_id="B3" value="38.50" spread="7.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Birth Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.9" spread="0.5"/>
                    <measurement group_id="B2" value="3.1" spread="0.4"/>
                    <measurement group_id="B3" value="3.0" spread=".45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Opioid Exposure Only</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Multi-Drug Exposure</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Length of Hospitalization</title>
        <description>How long the infant remains hospitalized.</description>
        <time_frame>Up to 4 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Therapy ALONE</title>
            <description>These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy Plus Aromatherapy</title>
            <description>These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.
lavender and chamomile essential oils: Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospitalization</title>
          <description>How long the infant remains hospitalized.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.8" spread="10.1"/>
                    <measurement group_id="O2" value="11.4" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Medication Therapy</title>
        <description>How long the infant requires medication to treat symptoms.</description>
        <time_frame>Up to 4 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Therapy ALONE</title>
            <description>These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy Plus Aromatherapy</title>
            <description>These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.
lavender and chamomile essential oils: Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Medication Therapy</title>
          <description>How long the infant requires medication to treat symptoms.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="10.1"/>
                    <measurement group_id="O2" value="7.4" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.05</p_value>
            <p_value_desc>0.05 is the calculated p-value (not the threshold for statistical significance)</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Until release from the hospital (up to 50 days post-birth)</time_frame>
      <desc>Data were collected from hospital electronic medical records.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Therapy ALONE</title>
          <description>These infants receive standard care ONLY, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.</description>
        </group>
        <group group_id="E2">
          <title>Standard Therapy Plus Aromatherapy</title>
          <description>These infants will receive aromatherapy, consisting of Lavender and Chamomile essential oils, in addition to standard care, which includes morphine replacement therapy, infant massage, PT, OT, and music therapy.
lavender and chamomile essential oils: Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Interpretation is limited by being a single-center, open-label trial.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>John Bauer, MD</name_or_title>
      <organization>University of Kentucky</organization>
      <phone>859-218-2927</phone>
      <email>john.bauer@uky.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

